ID   OMJ
AC   CVCL_WH39
DR   Wikidata; Q98128344
RX   PubMed=24035468;
RX   PubMed=27292541;
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; None_reported; -; Zygosity=- (PubMed=24035468).
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
RX   PubMed=24035468; DOI=10.1016/j.tvjl.2013.08.003;
RA   Ito K., Kobayashi M., Kuroki S., Sasaki Y., Iwata T., Mori K.,
RA   Kuroki T., Ozawa Y., Tetsuka M., Nakagawa T., Hiroi T., Yamamoto H.,
RA   Ono K., Washizu T., Bonkobara M.;
RT   "The proteasome inhibitor bortezomib inhibits the growth of canine
RT   malignant melanoma cells in vitro and in vivo.";
RL   Vet. J. 198:577-582(2013).
//
RX   PubMed=27292541; DOI=10.1111/jvp.12336;
RA   Kuroki S., Kobayashi M., Tani H., Miyamoto R., Kurita S., Tamura K.,
RA   Ono K., Washizu T., Bonkobara M.;
RT   "Selective growth inhibition by suppression of F1Fo ATPase in canine
RT   malignant melanoma cell lines.";
RL   J. Vet. Pharmacol. Ther. 40:101-104(2017).
//